UNSPSC 51201605: Encephalitis virus vaccine

This clasification denotes vaccines to treat inflammation of brain parenchymal tissue as a result of viral infection, typically primary or secondary manifestation of togaviridae infections; herpesviridae infections; adenoviridae infections; flaviviridae infections; bunyaviridae infections; picornaviridae infections; paramyxoviridae infections; orthomyxoviridae infections; retroviridae infections; and arenaviridae infections.

UNSPSC 51201605 Encephalitis virus vaccine (Commodity) captures viral immunization products procured by state health departments for public health programs, though the single recent opportunity posted under this code involves a yellow fever vaccine rather than encephalitis-specific formulations. The Mississippi State Department of Health announced a sole-source procurement on July 13, 2026 for yellow fever vaccine from Sanofi Pasteur, Inc., reflecting the reality that state health agencies use this taxonomy entry for vaccines addressing arboviral and vector-borne diseases within the encephalitis family. State and local governments solicit under this code through health department procurement offices when filling public health inventory for vaccination campaigns, disease-control initiatives, or emergency preparedness stockpiling, though the frequency and specificity of opportunities appear limited relative to broader vaccine categories.

The recent activity is confined to the South, with Mississippi State Department of Health's sole-source notice being the only posted opportunity in the recent-opportunities block. The procurement involves no disclosed quantity, contract term, estimated value, or pricing; objections to the sole-source designation were due August 3, 2026 at 10:00 a.m. CST, directed to Cynthia Brasher at the Mississippi State Department of Health Purchasing Department. If substantiated objections demonstrating alternative sources are received, the department will convert to a competitive ITB or RFP process; if sole-source status is upheld, the decision is subject to Public Procurement Review Board appeal. This code shows minimal recent activity overall, and the single opportunity does not align closely with the encephalitis-specific nominal scope.